{
  "id": 3890,
  "url": "https://nnemf.org/research/3890-pulmonary-vein-isolation-by-circumferential-radiofrequency-lesions-in",
  "title": "Pulmonary vein isolation by circumferential radiofrequency lesions in atrial fibrillation. From substrate to clinical outcome.",
  "authors": [
    "C Pappone",
    "V Santinelli"
  ],
  "journal": "Annali dell'Istituto superiore di sanita",
  "year": "2001",
  "doi": null,
  "pmid": "11889957",
  "abstract": "Circumferential ablation around pulmonary vein ostia by CARTO system was performed in 98 patients with paroxysmal and 29 with permanent atrial fibrillation (AF). Preablation and postablation activation, propagation and voltage maps were obtained. A total of 135 +/- 18 radiofrequency pulses were delivered. After a follow-up of 14.7 +/- 3.3 months, 84 patients with paroxysmal and 22 with chronic AF are in sinus rhythm and 75 of them without antiarrhythmics. Only the area extent of low voltage potentials within and just around the lesions distinguished patients with and without successful ablation. Pulmonary vein isolation is an effective procedure to cure resistant AF; the extent of lesion area around pulmonary vein ostia may be crucial in predicting the outcome.",
  "effect": "benefit",
  "evidence": "insufficient",
  "extraction": {
    "studyType": "other",
    "studyTypeLabel": "Other",
    "effectDirection": "benefit",
    "evidenceLabel": "Insufficient",
    "population": "Patients with paroxysmal (n=98) and permanent/chronic (n=29) atrial fibrillation undergoing circumferential ablation around pulmonary vein ostia (CARTO system)",
    "sampleSize": "127",
    "exposure": "RF",
    "confidencePct": "66",
    "peerReviewed": "yes",
    "mainFindings": "Circumferential pulmonary vein ostial ablation was performed in 127 AF patients with 135 ± 18 radiofrequency pulses. After 14.7 ± 3.3 months follow-up, 84 paroxysmal and 22 chronic AF patients were in sinus rhythm, and 75 of those were without antiarrhythmic drugs. The extent of low-voltage potentials within and just around the lesions distinguished patients with and without successful ablation.",
    "outcomes": [
      "Sinus rhythm after follow-up",
      "Need for antiarrhythmic drugs after ablation",
      "Electroanatomic mapping measures (activation/propagation/voltage maps",
      "low-voltage area extent)",
      "Ablation success vs failure"
    ],
    "limitations": [
      "No study design details provided in abstract (e.g.",
      "randomization/control group not described)",
      "Frequency",
      "power",
      "or dosimetry of radiofrequency energy not reported",
      "Outcome definitions and ascertainment methods not described in abstract"
    ],
    "keywords": [
      "atrial fibrillation",
      "pulmonary vein isolation",
      "circumferential ablation",
      "radiofrequency lesions",
      "CARTO",
      "electroanatomic mapping",
      "sinus rhythm",
      "antiarrhythmic drugs"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"other\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"medical radiofrequency ablation\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Patients with paroxysmal (n=98) and permanent/chronic (n=29) atrial fibrillation undergoing circumferential ablation around pulmonary vein ostia (CARTO system)\",\n  \"sample_size\": 127,\n  \"outcomes\": [\n    \"Sinus rhythm after follow-up\",\n    \"Need for antiarrhythmic drugs after ablation\",\n    \"Electroanatomic mapping measures (activation/propagation/voltage maps; low-voltage area extent)\",\n    \"Ablation success vs failure\"\n  ],\n  \"main_findings\": \"Circumferential pulmonary vein ostial ablation was performed in 127 AF patients with 135 ± 18 radiofrequency pulses. After 14.7 ± 3.3 months follow-up, 84 paroxysmal and 22 chronic AF patients were in sinus rhythm, and 75 of those were without antiarrhythmic drugs. The extent of low-voltage potentials within and just around the lesions distinguished patients with and without successful ablation.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"No study design details provided in abstract (e.g., randomization/control group not described)\",\n    \"Frequency, power, or dosimetry of radiofrequency energy not reported\",\n    \"Outcome definitions and ascertainment methods not described in abstract\"\n  ],\n  \"evidence_strength\": \"insufficient\",\n  \"confidence\": 0.66,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"atrial fibrillation\",\n    \"pulmonary vein isolation\",\n    \"circumferential ablation\",\n    \"radiofrequency lesions\",\n    \"CARTO\",\n    \"electroanatomic mapping\",\n    \"sinus rhythm\",\n    \"antiarrhythmic drugs\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"medical-rf-ablation\",\n      \"weight\": 0.9,\n      \"reason\": \"Study involves therapeutic radiofrequency ablation (pulmonary vein isolation) rather than environmental EMF exposure.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/11889957/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3890",
  "updated": "2026-02-13 07:40:19"
}